These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38511244)

  • 1. Utilization of broad- versus narrow-spectrum antibiotics for the treatment of outpatient community-acquired pneumonia among adults in the United States.
    Nickel KB; Durkin MJ; Olsen MA; Sahrmann JM; Neuner E; O'Neil CA; Butler AM;
    Pharmacoepidemiol Drug Saf; 2024 Apr; 33(4):e5779. PubMed ID: 38511244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multistep antimicrobial stewardship intervention on antibiotic prescriptions and treatment duration in children with pneumonia.
    Rossin S; Barbieri E; Cantarutti A; Martinolli F; Giaquinto C; Da Dalt L; Doná D
    PLoS One; 2021; 16(10):e0257993. PubMed ID: 34705849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Empiric Antibiotic Treatment Regimens for Hospitalized, Non-severe Community-acquired Pneumonia: A Retrospective, Multicenter Cohort Study.
    Reeves SD; Hartmann AP; Tedder AC; Juang PA; Hofer M; Kollef MH; Micek ST; Betthauser KD
    Clin Ther; 2024 Apr; 46(4):338-344. PubMed ID: 38403509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of β-Lactam Plus Macrolide Versus Fluoroquinolone on 30-Day Readmissions for Community-Acquired Pneumonia.
    Gilbert TT; Arfstrom RJ; Mihalovic SW; Dababneh AS; Varatharaj Palraj BR; Dierkhising RA; Mara KC; Lessard SR
    Am J Ther; 2020; 27(2):e177-e182. PubMed ID: 30418221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of community-acquired pneumonia in adults.
    Watkins RR; Lemonovich TL
    Am Fam Physician; 2011 Jun; 83(11):1299-306. PubMed ID: 21661712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variability in Antibiotic Prescribing for Community-Acquired Pneumonia.
    Handy LK; Bryan M; Gerber JS; Zaoutis T; Feemster KA
    Pediatrics; 2017 Apr; 139(4):. PubMed ID: 28270546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic Choice and Clinical Outcomes in Ambulatory Children with Community-Acquired Pneumonia.
    Lipsett SC; Hall M; Ambroggio L; Hersh AL; Shah SS; Brogan TV; Gerber JS; Williams DJ; Grijalva CG; Blaschke AJ; Neuman MI
    J Pediatr; 2021 Feb; 229():207-215.e1. PubMed ID: 33045236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of empiric antibiotics for community-acquired pneumonia.
    Queen MA; Myers AL; Hall M; Shah SS; Williams DJ; Auger KA; Jerardi KE; Statile AM; Tieder JS
    Pediatrics; 2014 Jan; 133(1):e23-9. PubMed ID: 24324001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The etiology of community-acquired pneumonia in Australia: why penicillin plus doxycycline or a macrolide is the most appropriate therapy.
    Charles PG; Whitby M; Fuller AJ; Stirling R; Wright AA; Korman TM; Holmes PW; Christiansen KJ; Waterer GW; Pierce RJ; Mayall BC; Armstrong JG; Catton MG; Nimmo GR; Johnson B; Hooy M; Grayson ML;
    Clin Infect Dis; 2008 May; 46(10):1513-21. PubMed ID: 18419484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review.
    Oosterheert JJ; Bonten MJ; Hak E; Schneider MM; Hoepelman IM
    J Antimicrob Chemother; 2003 Oct; 52(4):555-63. PubMed ID: 12972448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad- versus Narrow-Spectrum Oral Antibiotic Transition and Outcomes in Health Care-associated Pneumonia.
    Buckel WR; Stenehjem E; Sorensen J; Dean N; Webb B
    Ann Am Thorac Soc; 2017 Feb; 14(2):200-205. PubMed ID: 27690519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Treatment Failure Rates of Respiratory Fluoroquinolones or β-Lactam + Macrolide Versus β-Lactam Alone in the Treatment for Community-Acquired Pneumonia in Adult Outpatients: An Analysis of a Nationally Representative Claims Database.
    Lee MG; Lee SH; Chang SS; Chan YL; Pang L; Hsu SM; Lee CC
    Medicine (Baltimore); 2015 Sep; 94(39):e1662. PubMed ID: 26426664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.
    Frei CR; Jaso TC; Mortensen EM; Restrepo MI; Raut MK; Oramasionwu CU; Ruiz AD; Makos BR; Ruiz JL; Attridge RT; Mody SH; Fisher A; Schein JR
    Curr Med Res Opin; 2009 Apr; 25(4):859-68. PubMed ID: 19231913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community-Acquired Pneumonia in Adults: Diagnosis and Management.
    Kaysin A; Viera AJ
    Am Fam Physician; 2016 Nov; 94(9):698-706. PubMed ID: 27929242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic treatment patterns, costs, and resource utilization among patients with community acquired pneumonia: a US cohort study.
    Llop CJ; Tuttle E; Tillotson GS; LaPlante K; File TM
    Hosp Pract (1995); 2017 Feb; 45(1):1-8. PubMed ID: 28064542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to infectious diseases society of America guidelines for empiric therapy for patients with community-acquired pneumonia in a commercially insured cohort.
    Wu JH; Howard DH; McGowan JE; Turpin RS; Henry Hu X
    Clin Ther; 2006 Sep; 28(9):1451-61. PubMed ID: 17062317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical coverage in community-acquired pneumonia after outpatient beta-lactam monotherapy.
    van Werkhoven CH; van de Garde EMW; Oosterheert JJ; Postma DF; Bonten MJM
    Respir Med; 2017 Aug; 129():145-151. PubMed ID: 28732822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review.
    Al Saeedy D; Gillani SW; Al-Salloum J; Moosvi A; Eissa M; Gulam SM
    Curr Pediatr Rev; 2020; 16(4):307-313. PubMed ID: 32895041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outpatient Antimicrobial Stewardship: Targets for Community-acquired Pneumonia.
    Wattengel BA; Sellick JA; Skelly MK; Napierala R; Schroeck J; Mergenhagen KA
    Clin Ther; 2019 Mar; 41(3):466-476. PubMed ID: 30739721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.